RI
Insider
Robert Mittendorff II
DirectorRobert Mittendorff II (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Carlsmed, Inc. (CARL). Across 1 priced purchase filing, the average 21-session return was -15.0% from execution and -15.0% from disclosure (delay-adjusted; derived). The largest single filing was $20.0M of CARL (1,333,333 sh × $15.00, as filed), executed Jul 24 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-15.0%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-15.0%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
0d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$20.0M
shares × price, as filed
Last traded
Jul 24 2025
Filed Jul 24 2025
Median ADV $2.3M across their filed names
Open performance→Volume by month
Buys $20.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
CARLRecent filings
CARLPURCHASE
Carlsmed, Inc.
View filing →
$20.0M1,333,333 sh × $15.00
Exec Jul 24 2025
Filed Jul 24 2025 · 8:31 PM ET